Literature DB >> 8471817

A novel variety of atypical Pneumocystis carinii infection after long-term prophylactic pentamidine inhalation in an AIDS patient: large lower lobe pneumocystoma.

H Albrecht1, H J Stellbrink, S Fenske, J Koch, H Greten.   

Abstract

Atypical pulmonary manifestations of Pneumocystis carinii infection and fair numbers of extrapulmonary and disseminated infections have lately been documented in patients with human immunodeficiency virus infection treated prophylactically with inhalative pentamidine. We report the case of a 32-year-old homosexual patient who was assessed for complaints of night sweats, weight loss, and progressive malaise. The patient denied any respiratory tract symptoms such as cough, sputum production, pleuritic chest pain, or shortness of breath. Chest X-ray revealed two large round noncavitating lesions in the lower lobe of the right lung. Pneumocystomas were diagnosed by fine-needle aspiration. A 3-week course of intravenous high-dose cotrimoxazole resulted in amelioration of symptoms but no change in the radiographic appearance of the pulmonary lesions. Four months later the patient is alive and stable and is being treated with pentamidine inhalation of 300 mg per 2 weeks and two tablets of pyrimethamine sulfadoxine per week.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8471817     DOI: 10.1007/bf00184733

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  18 in total

Review 1.  [Atypical forms of AIDS-associated Pneumocystis carinii infection].

Authors:  S Ewig; D Niese
Journal:  Dtsch Med Wochenschr       Date:  1991-03-01       Impact factor: 0.628

2.  Pneumocystis carinii pneumonia presenting as localized nodular densities.

Authors:  A S Cross; R T Steigbigel
Journal:  N Engl J Med       Date:  1974-10-17       Impact factor: 91.245

3.  Systemic dissemination of Pneumocystis carinii in a patient with acquired immunodeficiency syndrome.

Authors:  M B Amin; M P Abrash; E Mezger; G F Sekerak
Journal:  Henry Ford Hosp Med J       Date:  1990

4.  A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia.

Authors:  B Hirschel; A Lazzarin; P Chopard; M Opravil; H J Furrer; S Rüttimann; P Vernazza; J P Chave; F Ancarani; V Gabriel
Journal:  N Engl J Med       Date:  1991-04-18       Impact factor: 91.245

5.  Prevention of Pneumocystis carinii pneumonia relapse by pentamidine aerosol in zidovudine-treated AIDS patients.

Authors:  P M Girard; R Landman; C Gaudebout; A Lepretre; P Lottin; C Michon; P De Truchis; S Matheron; F Camus; R Farinotti
Journal:  Lancet       Date:  1989-06-17       Impact factor: 79.321

6.  Granulomatous Pneumocystis carinii pneumonia in three patients with the acquired immune deficiency syndrome.

Authors:  I J Bleiweiss; J S Jagirdar; M J Klein; J L Siegel; D J Krellenstein; A R Gribetz; J A Strauchen
Journal:  Chest       Date:  1988-09       Impact factor: 9.410

7.  Aerosolized pentamidine: effect on diagnosis and presentation of Pneumocystis carinii pneumonia.

Authors:  K M Jules-Elysee; D E Stover; M B Zaman; E M Bernard; D A White
Journal:  Ann Intern Med       Date:  1990-05-15       Impact factor: 25.391

8.  Disseminated Pneumocystis carinii infection in a patient with acquired immunodeficiency syndrome.

Authors:  P D Unger; M Rosenblum; S E Krown
Journal:  Hum Pathol       Date:  1988-01       Impact factor: 3.466

9.  Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial.

Authors:  G S Leoung; D W Feigal; A B Montgomery; K Corkery; L Wardlaw; M Adams; D Busch; S Gordon; M A Jacobson; P A Volberding
Journal:  N Engl J Med       Date:  1990-09-20       Impact factor: 91.245

10.  Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus.

Authors: 
Journal:  MMWR Suppl       Date:  1989-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.